Predictors of course in obsessive-compulsive disorder: Logistic regression versus Cox regression for recurrent events

Acta Psychiatrica Scandinavica

Volumn 116, Issue 3, 2007, Pages 201-210

  Kempe, P T ^a   Van Oppen, P ^a   De Haan, E ^b   Twisk, J W R ^a   Sluis, A ^a   Smit, J H ^a   Van Dyck, R ^a   Van Balkom, A J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Follow up studies; Forecasting; Obsessive compulsive disorder; Remission induction; Treatment outcome

Indexed keywords

FLUVOXAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FORECASTING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROSIS; OBSESSIVE COMPULSIVE DISORDER; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; REMISSION; SYMPTOM;

ANTI-ANXIETY AGENTS; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; DESENSITIZATION, PSYCHOLOGIC; FLUVOXAMINE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; NEUROTIC DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERSONALITY INVENTORY; PROPORTIONAL HAZARDS MODELS; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 34547130542     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2007.00997.x     Document Type: Article

References (43)

1. Van Balkom AJLM, van Oppen P, Vermeulen AWA, van Dyck R, Nauta MCE, Vorst HCM. A meta-analysis on the treatment of obsessive compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 1994 14 : 359 381.
2. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis 1. Psychopharmacology (Berl) 1998 136 : 205 216.
3. Hembree EA, Riggs DS, Kozak MJ, Franklin ME, Foa EB. Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder. CNS Spectr 2003 8 : 381.
4. Schruers K, Koning K, Luermans J, Haack MJ, Griez E. Obsessive-compulsive disorder: a critical review of therapeutic perspectives 2. Acta Psychiatr Scand 2005 111 : 261 271.
5. O'Connor KP, Aardema F, Robillard S et al. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand 2006 113 : 408 419.
6. Lochner C, Stein DJ. Heterogeneity of obsessive-compulsive disorder: a literature review. Harv Rev Psychiatry 2003 11 : 113 132.
7. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995 56 : 368 373.
8. Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993 13 : 210 213.
9. Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand 2006 113 : 440 446.
10. Denys D, Burger H, van Megen H, de Geus F, Westenberg H. A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2003 18 : 315 322.
11. Ackerman DL, Greenland S, Bystritsky A. Use of receiver-operator characteristic (ROC) curve analysis to evaluate predictors of response to clomipramine therapy. Psychopharmacol Bull 1996 32 : 157 165.
12. Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994 14 : 247 254.
13. Ackerman DL, Greenland S, Bystritsky A. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1998 18 : 185 192.
14. de Haan E, van Oppen P, van Balkom AJ, Spinhoven P, Hoogduin KA, van Dyck R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatr Scand 1997 96 : 354 361.
15. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999 156 : 1409 1416.
16. DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull 1990 26 : 54 59.
17. Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 2001 21 : 488 492.
18. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry 1989 46 : 36 44.
19. Tollefson GD, Rampey AH Jr., Potvin JH et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994 51 : 559 567.
20. Mundo E, Bareggi SR, Pirola R, Bellodi L. Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable?. Biol Psychiatry 1999 45 : 290 294.
21. Eisen JL, Goodman WK, Keller MB et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry 1999 60 : 346 351.
22. Emmelkamp PMG, Hoekstra RJ, Visser A. The behavioral treatment of obsessive-compulsive disorder: prediction of outcome at 3.5-year follow-up. In : Pichot P, Berner R, Wolf R, Thau K. eds. Psychiatry: the state of the art. New York : Plenum, 1985 : 265 270.
23. Foa EB, Grayson JB, Steketee GS, Doppelt HG, Turner RM, Latimer PR. Success and failure in the behavioral treatment of obsessive-compulsives. J Consult Clin Psychol 1983 51 : 287 297.
24. Cavedini P, Erzegovesi S, Ronchi P, Bellodi L. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. Eur Neuropsychopharmacol 1997 7 : 45 49.
25. Steketee G, Chambless DL. Methodological issues in the prediction of treatment outcome. Clin Psychol Rev 1992 12 : 387 400.
26. van Oppen P, de Haan E, van Balkom AJ, Spinhoven P, Hoogduin K, van Dyck R. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 1995 33 : 379 390.
27. van Oppen P, Van Balkom AJLM, de Haan E, van Dyck R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive compulsive disorder: a 5-year follow-up. J Clin Psychiatry 2005 66 : 1415 1422.
28. van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis 1998 186 : 492 499.
29. Goodman WK, Price LH, Rasmussen SA et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989 46 : 1006 1011.
30. van Oppen P, Hoekstra RJ, Emmelkamp PM. The structure of obsessive-compulsive symptoms. Behav Res Ther 1995 33 : 15 23.
31. Emmelkamp PM, Kraaijkamp HJ, van den Hout MA. Assessment of obsessive-compulsive disorder. Behav Modif 1999 23 : 269 279.
32. Di Nardo PA, O'Brien GT, Barlow DH, Waddell MT, Blanchard EB. Reliability of DSM-III anxiety disorder categories using a new structured interview. Arch Gen Psychiatry 1983 40 : 1070 1074.
33. Hyler SE, Rieder RO. Personality diagnostic questionnaire revised (PDQ-R). New York : New York State Psychiatric Institute, 1987.
34. Derogatis LR. SCL-90-R, administration, scoring & procedures manual-I for the R(evised) version. Baltimore, MD : Clinical Psychometrics Research Unit, Johns Hopkins University School of Medicine, 1977.
35. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961 4 : 561 571.
36. Koopmans PC, Sanderman R, Timmerman I, Emmelkamp PMG The irrational beliefs inventory (IBI): development and psychometric evaluation. Eur J Psychol Assess 1994 10 : 15 27.
37. SPSS. Statistical package for the social sciences, advanced statistics reference guide, release 7.5. Chicago, IL : SPSS, 1997.
38. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991 59 : 12 19.
39. Tolin DF, Abramowitz JS, Diefenbach GJ. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale. J Clin Psychiatry 2006 66 : 1549 1557.
40. Twisk JWR. Applied longitudinal data analysis for epidemiology. A practical guide. Cambridge, UK : Cambridge Univerity Press, 2003.
41. Twisk JW, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health 2005 59 : 706 710.
42. Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York : John Wiley, 1999.
43. Stata. STATA reference manual, release 7. College Station, TX : Stata Press, 2001.